Literature DB >> 6337741

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.

B L Kramer, B M Massie, N Topic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6337741     DOI： 10.1161/01.cir.67.4.807

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  44 in total

Review 1.  Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.

Authors:  J N Cohn
Journal:  Drugs       Date:  1994       Impact factor: 9.546

2.  Low-dose enalapril in severe chronic heart failure.

Authors:  C G Brilla; B Krämer; H M Hoffmeister; W Müller-Schauenburg; T Risler; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

Review 3.  Modern treatment of heart failure.

Authors:  A D Timmis
Journal:  BMJ       Date:  1988-07-09

4.  Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.

Authors:  M Packer; N Medina; M Yushak; W H Lee
Journal:  Br Heart J       Date:  1985-09

5.  Treatment of chronic heart failure: a review of recent drug trials.

Authors:  D P Lipkin; P A Poole-Wilson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

6.  Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects.

Authors:  H Stern; J Weil; T Genz; W Vogt; K Bühlmeyer
Journal:  Pediatr Cardiol       Date:  1990-01       Impact factor: 1.655

7.  Captopril in heart failure. A double blind controlled trial.

Authors:  J G Cleland; H J Dargie; G P Hodsman; S G Ball; J I Robertson; J J Morton; B W East; I Robertson; G D Murray; G Gillen
Journal:  Br Heart J       Date:  1984-11

8.  Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study.

Authors:  B Herrlin; O Nyquist; C Sylvén
Journal:  Br Heart J       Date:  1991-09

Review 9.  The role of vasodilator therapy in the treatment of severe chronic heart failure.

Authors:  M Packer
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.

Authors:  F X Kleber; L Niemöller; W Doering
Journal:  Br Heart J       Date:  1992-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.